Clinical significance of the anti-GQ(1b)-antibodies in patients with Miller-Fisher-syndrome;Klinische Bedeutung der Anti-GQ(1b)-Antikorper bei Patienten mit Miller-Fisher-Syndrom

Aktuelle Neurologie

Volumn 24, Issue 2, 1997, Pages 67-70

  Willimann, P ^a   Lechner Scott, J ^a,b   Ferracin, F ^a   Miescher, G ^a   Steck, A J ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Neurologische Universitatsklinik Basel   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY;

ADULT; AGED; AREFLEXIA; ARTICLE; ATAXIA; CEREBROSPINAL FLUID; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; MALE; OPHTHALMOPLEGIA; SUBCLAVIAN STEAL SYNDROME; T LYMPHOCYTE;

EID: 0030915874     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017782     Document Type: Article

References (24)

1. 1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J. Neuroimm. 32 (1991) 223-230
2. Arnason, B. G. W., B. Soliven: Acute inflammatory demyelimating polyradiculoneuropathy. In: Dyck, P. J., P. K. Thomas. W. B. Saunders (Eds.): Peripheral Neuropathy: Philadelphia (1993) 1437-1497
3. Asbury, A. K.: Gangliosides and peripheral neuropathies: an overview. Prog. Brain Res. 101 (1994) 279-287
4. 1b, IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome. Neurology 43 (1993) 1911 -1917
5. 1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31 (1992) 677-679
6. 1b. Schweiz Arch. Neurol. Psychiatrie 146 (1995) 180-184
7. 1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann. Neurol. 37 (1995) 260-264
8. Fisher, M.: An unusual variant of the acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 225 (1956) 57-65
9. Fross, R. D., J. R. Daube: Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 37 (1987) 1493
10. Hammers, A., R. J. Hardie: Miller-Fisher syndrome with rapid recovery. Lancet 343 (1994) 1290
11. Hankey, G. J.: Guillain Barré syndrome in Western Australia 1980 -1985. Med. J. Aust. 146 (1987) 130
12. Jacobs, B. C., H. Endtz, F. G. van der Meche et al: Electrophysiological studies in Miller Fisher syndrome. Neurology 34 (1984) 685
13. Kaldor, J., B. R. Speed: Guillain-Barré syndrome and campylobacter jejuni: a serological study. Br. Med. J. 288 (1984) 1867-1870
14. Kitamura, M., M. Iwamori, Y. Nagai: Interaction between Clostridium botulinum neurotoxin and gangliosides. Biochem. Biophys. Acta 628 (1980) 328-335
15. 1 antibody testing. Muscle Nerve 17 (1994) 100-104
16. Pestronk, A., R. N. Adams, R. W. Kincl et al.: Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders. Neurology 39 (1989) 628-633
17. Rees, J. H., S. E. Soudain, N. A. Gregson et al.: Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333 (1995) 1374-1379
18. Roberts, M., H. Willison, A. Vinvent et al.: Serum factor in Miller Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 343 (1994) 454-455
19. Steck, A. J., D. Burger, S. Picasso et al.: Gangliosides and related glycoconjugates in myelin: relationship to peripheral neuropathies. Prog. Brain Res. 101 (1994) 305-312
20. Steck, A. J., L. Kappos: Changing concepts in inflammatory and paraneoplastic neuropathies. Current Neurol. 16 (1996) 191-212
21. 1b antibodies in Miller Fisher syndrome. J. Neuroimmunology 50 (1994) 159-165
22. Willison, H. J.: Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J. Neurol. Neurosurg. Psychiatry 57 (1994) 1303-1307
23. Yuki, N., T. Miyatake, T. Obsawa: Beneficial effect of plasmapheresis on Fisher's syndrome. Muscle Nerve 16 (1993) 1267-1268
24. 1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36 (1994) 791-793